Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,470
Closed -$294K 207
2026
Q1
$294K Buy
10,470
+213
+2% +$5.67K 0.14% 121
2025
Q4
$255K Sell
10,257
-775
-7% -$19.5K 0.12% 133
2025
Q3
$281K Sell
11,032
-103
-0.9% -$2.54K 0.14% 122
2025
Q2
$270K Buy
11,135
+837
+8% +$19.5K 0.15% 119
2025
Q1
$261K Sell
10,298
-110
-1% -$2.88K 0.2% 82
2024
Q4
$276K Buy
+10,408
New +$282K 0.25% 66

Other funds holding PFE

Plan A Wealth's PFE Position: Q2 2026 in Review

Plan A Wealth sold out of Pfizer (PFE) in Q2 2026, closing a stake of 10,470 shares — an estimated $294K sold.

Plan A Wealth first reported a position in PFE in Q4 2024 and held it in 6 quarters. The position peaked at $294K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Plan A Wealth reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Plan A Wealth sold 10,470 Pfizer shares in Q2 2026, an estimated $294K.
  • Plan A Wealth first reported a position in Pfizer in Q4 2024 and held it in 6 quarters.
  • Plan A Wealth's Pfizer position peaked at $294K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Plan A Wealth's 13F filing for Q2 2026, filed 14 Jul 2026.